Published Date: 30-Sep-2022
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report, published by KBV research, The Global Cardiac Safety Services Market size is expected to reach $1.1 billion by 2028, rising at a market growth of 11.1% CAGR during the forecast period.
The Standalone segment is showcasing a CAGR of 12.9% during (2022 - 2028). Depending on their needs, some end users select particular services to be carried out at various stages of clinical studies. CROs, pharmaceutical, and biopharmaceutical businesses primarily use standalone services for preclinical, clinical, and drug discovery trials. These services are favored since they are economical.
The Pharmaceutical & Biopharmaceutical Companies segment is leading the Global Cardiac Safety Services Market by End User in 2021 thereby, achieving a market value of $864.1 Million by 2028. Pharmaceutical businesses invest in R&D to release superior and cutting-edge items on the market. According to current trends, leading pharmaceutical companies are enhancing their R&D effectiveness through significant R&D expenditures to realize returns on their investments over the long term and through cooperative R&D efforts.
The Blood Pressure Measurement segment has shown the growth rate of 10.8% during (2022 - 2028). In order to get a precise blood pressure reading and better understand the risk for heart disease and stroke, blood pressure testing is essential. A major and manageable risk factor causing cardiovascular events is hypertension. When the systolic (upper) blood pressure is at or above 130 and the diastolic (lower) blood pressure is at or above 80, one is said to have hypertension.
The North America market dominated the Global Cardiac Safety Services Market by Region in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $403.1 Million by 2028. The Europe market is exhibiting a CAGR of 10.6% during (2022 - 2028). Additionally, The Asia Pacific market would showcase a CAGR of 12% during (2022 - 2028).
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Koninklijke Philips N.V., Clario, IQVIA Holdings, Inc., Laboratory Corporation of America Holdings, Pharmaceutical Product Development, Inc., SGS S.A., Banook Group, Biotrial Research SAS, Certara, Inc., and Celerion.
By End User
By Type of Service
Unique Offerings from KBV Research